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The O-conotoxins are an intriguing class of conotox-
ins targeting various voltage-dependent sodium chan-
nels and molluscan calcium channels. In the current
study, we have shown MrVIA and MrVIB to be the first
known peptidic inhibitors of the transient tetrodotoxin-
resistant (TTX-R) Na current in rat dorsal root gan-
glion neurons, in addition to inhibiting tetrodotoxin-
sensitive Na currents. Human TTX-R sodium channels
are a therapeutic target for indications such as pain,
highlighting the importance of the O-conotoxins as po-
tential leads for drug development. Furthermore, we
have used NMR spectroscopy to provide the first struc-
tural information on this class of conotoxins. MrVIA and
MrVIB are hydrophobic peptides that aggregate in
aqueous solution but were solubilized in 50% acetoni-
trile/water. The three-dimensional structure of MrVIB
consists of a small -sheet and a cystine knot arrange-
ment of the three-disulfide bonds. It contains four back-
bone “loops” between successive cysteine residues that
are exposed to the solvent to varying degrees. The larg-
est of these, loop 2, is the most disordered part of the
molecule, most likely due to flexibility in solution. This
disorder is the most striking difference between the
structures of MrVIB and the known - and -conotoxins,
which along with the O-conotoxins are members of the
O superfamily. Loop 2 of -conotoxins has previously
been shown to contain residues critical for binding to
voltage-gated calcium channels, and it is interesting to
speculate that the flexibility observed in MrVIB may
accommodate binding to both sodium and molluscan
calcium channels.
Conotoxins are of great interest as ligands in neuroscience
and are valuable leads in drug design based on their specificity
and potency for therapeutically relevant receptors and ion
channels (1, 2). Several subtypes of one such ion channel, the
sodium channel, have been implicated in clinical states, includ-
ing pain (3–6), stroke (7, 8), and epilepsy (9, 10). Consequently,
conotoxins targeting voltage-gated sodium channels are not
only important for further characterization of the channel but
may themselves be useful as therapeutics.
The O-conotoxins, MrVIA and MrVIB from the venom of
Conus marmoreus (11), are a particularly interesting family of
conotoxins, because they block voltage-sensitive sodium chan-
nels (VSSC)1 but also interact with the calcium channel in
molluscan neurons. MrVIA and MrVIB have been shown to
block tetrodotoxin (TTX)-resistant (TTX-R) Na current in mol-
luscan neurons (11), the TTX-sensitive (TTX-S) Na current
through Nav1.2 expressed in Xenopus oocytes, and the TTX-S
Na current in hippocampal neurons (12). Despite the high
sequence conservation between MrVIA and MrVIB (only three
residues differ) the peptides behave differently at the calcium
channel in molluscan neurons. At low micromolar concentra-
tions, MrVIA acts as a calcium channel agonist, whereas
MrVIB acts as an antagonist. However, at higher doses both
toxins block the fast-inactivating calcium channel. This cross-
channel activity observed for O-conotoxins has been sug-
gested to represent an “intermediate” variant of conotoxin in
the diversification of one conotoxin structural family (13).
Comparison of the O-conotoxins with other conotoxins tar-
geting either sodium or calcium channels highlights some
striking differences as well as similarities. Although the
-conotoxins target VSSCs and contain three disulfide bonds,
the similarities to the O-conotoxins appear to end there.
Apart from the cysteine residues there is no sequence homol-
ogy, and the spacings between the cysteine residues are signif-
icantly different, as shown in Fig. 1. Furthermore, MrVIA
inhibits mammalian VSSCs through a novel mechanism dis-
tinct from site 1 targeted by the -conotoxins, saxitoxin, and
tetrodotoxin (12).
The O-conotoxins show greater similarities to both the -
and -conotoxins than to the -conotoxins. These similarities
involve the spacings between the cysteine residues (Fig. 1) and
similar precursor sequences, and consequently all three fami-
lies have been placed in the O superfamily (11). Although the
sequence homology in the mature peptides is restricted to the
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cysteine residues for these three families, the O-conotoxins
are active at both the sodium and calcium channels similar to
the - and -conotoxins, respectively. It should be noted that
the action of -conotoxins at the VSSC is distinct from the
O-conotoxins, because they slow the rate of inactivation of
sodium channels resulting in channel activation.
The O-conotoxins are the first group of conotoxins reported
to inhibit TTX-R Na currents in molluscan neurons. To deter-
mine if O-conotoxins are able to inhibit both TTX-S and
TTX-R Na currents in vertebrate neurons, we assessed the
ability of MrVIA and MrVIB to inhibit TTX-S and TTX-R Na
currents in isolated rat dorsal root ganglion (DRG) neurons.
DRG neurons, which express a variety of TTX-S and TTX-R
VSSCs, constitute the first connection between the peripheral
afferents and the central nervous system and contain the cell
bodies of small, unmyelinated C-fibers important for sensory
transmission, including pain.
To date, there is no structural information available on the
O-conotoxin family despite their sequences being discovered
nearly a decade ago (11). This is likely the case because only
limited amounts of native peptides may be isolated, and syn-
thetic derivatives of the peptides are difficult to oxidize to the
correct disulfide connectivity and appear to aggregate in aque-
ous solution. In the present study, we have shown that titration
of the hydrophobic solvent acetonitrile into an aqueous solution
of MrVIB ameliorates the aggregation and allows high quality
NMR spectra to be recorded. We here report the three-dimen-
sional structure of native MrVIB and its effects on TTX-S and
TTX-R Na currents in rat DRG neurons.
EXPERIMENTAL PROCEDURES
Isolation of O-conotoxin MrVIA/MrVIB—Crude venom from the
venom duct of C. marmoreus (440 mg by protein estimation at A280 nm)
was fractionated by HPLC on a Vydac C18 semipreparative column
eluted at 3 ml/min with a gradient of 0% to 80% solvent B over 80 min
(solvent A, 0.1% trifluoroacetic acid) in H2O; solvent B, 0.09% trifluoro-
acetic acid in 90% acetonitrile and 10% H2O). The eluant was monitored
at 230 nM, and 1-min fractions were collected and analyzed by mass
spectrometry on an LCT, electrospray time-of-flight mass spectrometer
(MicroMass, Manchester, UK). Fractions exhibiting the desired mass
for MrVIA and MrVIB were further analyzed by analytical HPLC on a
Vydac C4 analytical column eluted at 1 ml/min with a gradient of 0% to
80% solvent B over a 40-min period (eluant monitored at 214 nm).
Further purification was obtained on a Phenomenex C4 semiprepara-
tive column eluted at 3 ml/min with a gradient of 0% to 80% solvent B
over 80 min (monitored at 230 nm). Fractions were further analyzed for
purity as before on the Vydac analytical C4 column, and their masses
were confirmed by ESTOF MS. Yields for MrVIA and MrVIB were each
1% of the crude venom.
Three-dimensional Structural Analysis
NMR Spectroscopy—Samples for 1H NMR measurements contained
1 mM peptide in various solvent conditions. Deuterated solvents were
obtained from Cambridge Isotope Laboratories, Woburn, MA. Spectra
were recorded between 290 and 308 K on a Bruker DMX 750 spectrom-
eter equipped with a shielded gradient unit. Two-dimensional NMR
spectra were recorded in phase-sensitive mode using time-proportional
phase incrementation for quadrature detection in the t1 dimension. The
two-dimensional experiments consisted of a TOCSY spectrum using an
MLEV-17 spin lock sequence with a mixing time of 80 ms, DQF-COSY,
ECOSY, and NOESY spectra with mixing times of 100–200 ms. Solvent
suppression was achieved using a modified water suppression by gra-
dient-tailored excitation (WATERGATE) sequence (14). Spectra were
acquired over 6024 Hz with 4096 complex data points in F2 and 512
increments in the F1 dimension.
3JNH-H coupling constants were meas-
ured from a one-dimensional spectrum or from the DQF-COSY
spectrum.
Spectra were processed on a Silicon Graphics Indigo workstation
using XWINNMR (Bruker) software. The t1 dimension was zero-filled to
2048 real data points, and 90° phase-shifted sine bell window functions
were applied prior to Fourier transformation. Chemical shifts were
referenced to the water resonance at 290 K.
Structure Calculations—Preliminary structures of MrVIB were cal-
culated using a torsion angle-simulated annealing protocol within the
program DYANA as described previously (15). Final structures were
calculated using simulated annealing and energy minimization proto-
cols within CNS version 1.1 (16). The starting structures were gener-
ated using random  and  dihedral angles and energy-minimized to
produce structures with the correct local geometry. A set of 50 struc-
tures was generated by a torsion angle-simulated annealing protocol
(17, 18). This protocol involves a high temperature phase comprising
4000 steps of 0.015 ps of torsion angle dynamics, a cooling phase with
4000 steps of 0.015 ps of torsion angle dynamics during which the
temperature is lowered to 0 K, and finally an energy minimization
phase comprising 500 steps of Powell minimization. Structures consist-
ent with restraints were subjected to further molecular dynamics and
energy minimization in a water shell, as described previously (19). The
refinement in explicit water involves the following steps. First, heating
to 500 K via steps of 100 K, each comprising 50 steps of 0.005 ps of
Cartesian dynamics. Second, 2500 steps of 0.005 ps of Cartesian dy-
namics at 500 K before a cooling phase where the temperature is
lowered in steps of 100 K, each comprising 2500 steps of 0.005 ps of
Cartesian dynamics. Finally, the structures were minimized with 2000
steps of Powell minimization. Structures were analyzed using PROMO-
TIF (20) and PROCHECK-NMR (21).
Electrophysiological Experiments
Preparation of DRG Neurons—DRGs were dissected from along the
length of the spinal cord of 7- to 12-day-old rats and treated with 1
mg/ml collagenase (type II, Worthington Biochemical Corp., Freehold,
NJ) in sterile physiological salt solution for 35 min at 37 °C. Ganglia
were subsequently triturated with a fine-bore glass pipette and resus-
pended in Dulbecco’s modified Eagle’s media supplemented with 10%
fetal calf serum and 1% penicillin/streptomycin, plated onto plastic
coverslips coated with poly-L-lysine, and stored at 37 °C in 95% O2:5%
CO2. Following 1–2 days in culture, neurons with a capacitance of 2–35
picofarads that were relatively free of neurites were selected for
experiments.
Electrophysiological Recordings from DRG Cells—Whole cell Na
currents were recorded from isolated DRG neurons using the whole cell
patch clamp recording technique. Patch pipettes (PG150T-7.5; Harvard
Apparatus Ltd., Edenbridge, Kent, UK) were pulled, fire-polished, and
had resistances of 0.8–1.5 M when filled with intracellular solution.
Membrane currents were recorded using either an EPC-7 (List Medical,
Darmstadt, Germany) or an Axopatch 200A patch clamp amplifier
(Axon Instruments Inc., Union City, CA), and voltage steps were gen-
erated from a PC Pentium computer using pCLAMP7 software and a
Digidata 1200 A interface (Axon Instruments Inc., Union City, CA).
Series resistance was routinely compensated by 70–80%. Capacitive
and leakage currents were digitally subtracted using a P/6 pulse
protocol.
Solutions and Toxins—Depolarization-activated Na currents in
DRG neurons were recorded using patch pipettes filled with an internal
solution containing (in mM): 10 NaCl, 130 CsF, 10 CsCl, 10 EGTA, 10
HEPES-CsOH, pH 7.2. The bath solution contained (in mM) 50 NaCl, 5
KCl, 1 MgCl2, 1 CaCl2, 10 glucose, 90 tetraethylammonium (TEA)-Cl,
10 Hepes-TEA-OH, pH 7.35. Depolarization-activated Ca2 channel
currents were recorded using Ba2 as a charge carrier and patch-
pipettes filled with an internal solution containing (in mM): 140 CsCl, 5
Cs4BAPTA, 5 MgATP, 1 MgCl2, 0.1 NaGTP, 10 HEPES-CsOH, pH 7.3.
FIG. 1. Primary sequences of MrVIA, MrVIB, and selected -
and -conotoxins. The cysteine residues are highlighted in bold, with
the disulfide connectivities indicated, and the three residues that differ
between MrVIA and MrVIB are highlighted with gray boxes. Standard
one-letter codes are used for the amino acid, except for hydroxyproline
(O), and the terminal glutamic acid of PIIIA is a pyroglutamic acid. The
cysteine spacing is similar in MrVIA/B, TxVIA, and MVIIA but different
from -conotoxin PIIIA.
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The extracellular solution contained (in mM): 140 TEA-Cl, 4 BaCl2, 10
D-glucose, 10 HEPES-TEA-OH, pH 7.3. In all solutions, osmolarity was
adjusted to 290–300 mosM with sucrose. Toxins were applied via a
gravity-fed perfusion system. O-conotoxins MrVIA and MrVIB were
dissolved in bath solution containing 0.01% Me2SO. Me2SO at this
concentration had no effects on Na currents.
Data Analysis—All data were analyzed using Clampfit 8 software
(Axon Instruments Inc., Union city, CA). Tetrodotoxin (TTX)-resistant
Na currents were recorded in the presence of 300 nM TTX, at least 5
min following bath perfusion. Cells that contained 90% current that
was abolished by application of 300 nM TTX were used to study toxin
effects on TTX-S Na current. In this case, TTX was applied at the
beginning of the experiment to classify the Na current and then
washed out. Data are expressed as means  S.E. with n indicating the
number of neurons used. Concentration-response curves were analyzed
using GraphPad Prism 2.0 (San Diego, CA) and fitted with a one-site
binding equation, Y  1/(1  10(xlog EC50)). KD values for kinetic exper-
iments were calculated using the following formulas: KD  Koff/Kon (M),
where *Koff 1/	off s
1 and *Kon 1/(	on- Koff/[toxin]) M
1.s1. Koff and
Kon were calculated from single exponential functions fitted to the
time-course curves using GraphPad Prism 2.0.
RESULTS
A preliminary analysis of MrVIA and MrVIB using NMR
spectroscopy revealed broad signals in aqueous solutions, in-
dicative of aggregation. A range of pH values and temperatures
did not improve the quality of the NMR spectra, but titration
with acetonitrile had a beneficial effect, as illustrated in Fig. 2.
The titration was carried out from 0 to 90% aqueous acetoni-
trile, but the highest quality spectra were observed at 50%, and
the peptides were insoluble in 100% acetonitrile. Methanol
titrations were also performed but did not enhance the quality
of the spectra. Both MrVIA and MrVIB behaved in a similar
manner, and further structural studies were performed only on
MrVIB.
Assignments of the NMR spectra of MrVIB were made using
two-dimensional homonuclear methods (22), and the 1H chem-
ical shifts are supplied as supplementary material. Chemical
shifts in the amide region are generally well dispersed, and the
relatively large number of resolved cross-peaks in the NOESY
spectrum allowed determination of a well defined structure for
most regions of the molecule. Interestingly, the amide proton of
the N-terminal alanine is visible in the TOCSY spectrum,
suggesting that it is involved in long-lived hydrogen bonds or is
otherwise protected from exchanging with the solvent. Peaks
from terminal amino groups are not normally observed in NMR
spectra of peptides.
There are four backbone loops between successive cysteine
residues of the O-conotoxins, as shown in Fig. 1. The residues
in loop 2, the largest of the four loops, display significantly
fewer NOEs than the other parts of the molecule. Furthermore,
one residue in this loop, Leu14, and the amide proton of Cys20
were not visible in the spectra and therefore could not be
assigned. Several residues gave stronger cross-peaks in the
TOCSY spectra recorded at 308 K compared with those re-
corded at 290 K, including Cys9, Phe16, and Tyr18. However, in
general the quality of the NOESY spectra was better at lower
temperatures, and thus structures were calculated from the
data recorded at 290 K.
Secondary Structure of MrVIB—Trends in the observed
chemical shifts provided a useful first insight into the second-
ary structure of MrVIB. Chemical shift indices (CSI (23)) for
the backbone -protons were calculated using the measured
chemical shifts, and random coil values (24) and are illustrated
in Fig. 3. Several of the residues have chemical shifts that
differ from the random coil values by more than 0.1 ppm and
hence have CSI values of 1, but there are no significant
stretches of either positive or negative CSI values, suggesting
that the structure is not dominated by either helices or

-sheets.
From a consideration of the experimental NOE, slow ex-
change and coupling patterns illustrated in Fig. 3, together
with some longer range NOEs between backbone protons, an
indication of the likely secondary structure was derived and is
schematically illustrated in Fig. 4. The major secondary struc-
tural element is a 
-sheet involving residues 24–25 and 30–31.
The presence of H(i1)-Hi NOE signals and the absence of
H(i1)-Hi NOE signals in the NOESY spectrum for all three
proline residues (Pro12, Pro21, and Pro27) confirms that their
X-Pro peptide bonds are in the trans conformation. It is not
uncommon that proline residues have cis peptide bonds when
adjacent to aromatic residues (25). This does not appear to be
the case for MrVIB, because, although Phe28 follows Pro27, the
peptide bond between Gly26 and Pro27 is in the trans confor-
mation. However, Phe28 adopts a positive phi angle that is
presumably necessary to stabilize this region of the molecule.
After completion of the assignments for the 50% acetonitrile/
water data, spectra at lower acetonitrile concentrations were
re-examined. These spectra showed fewer peaks than in 50%
acetonitrile, due to the broadening/disappearance of certain
residues. For example, in the spectra recorded at 25% acetoni-
trile/water several residues from loop 2 are not visible. The
absence of signals from residues in loop 2 suggests that they
are broadened, possibly as a result of intermediate exchange
between multiple conformations. These conformers may reflect
intermolecular interactions associated with the aggregation
observed in aqueous solution.
Structure Determination—Solution structures for MrVIB
were determined using simulated annealing, including experi-
mental distance restraints and dihedral angle restraints. Of
the final 50 calculated structures, the 20 lowest energy struc-
tures consistent with experimental data were chosen to repre-
sent the family of MrVIB solution structures as shown in Fig.
5. The disulfide bond connectivities used in the structure cal-
culations were those reported by McIntosh et al. (11) (Cys2-
Cys20, Cys9-Cys25, and Cys19-Cys30). They were determined
using chemical synthesis with a selective protection strategy
for two of the cysteine residues.
A summary of the structural statistics for this family is given
in Table I. The structures are in agreement with the experi-
mental data, with no distance violation exceeding 0.3 Å and no
dihedral angle violation exceeding 3°. Residues 4–6 and 19–31
are well defined with r.m.s.d. values of 0.29 Å, but the sparsity
of NOEs for the remaining residues, particularly residues
8–18, results in poor definition in the other regions of the
molecule. The disorder for residues 8–18 appears to be a result
of conformational flexibility and not just the lack of NOEs,
FIG. 2. 1H NMR spectra of MrVIB. One-dimensional spectra were
recorded in H2O, 20% CD3CN, and 50% CD3CN on a 750-MHz spec-
trometer at 290 K.
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based on the broadened peaks observed for several residues in
this region. Fig. 6 shows a region of the NOESY spectrum
highlighting the broader peaks observed for Val11 and Ile13
compared with other peaks in the spectrum.
An analysis of the family of structures using the program
PROMOTIF (20) shows that the main element of secondary
structure of MrVIB is an anti-parallel 
-sheet, consistent with
the prediction from the NMR chemical shift, coupling, and
NOE data. The strands of the 
-sheet consist of residues 24–25
and 30–31 with an inverse  turn between residues 26 and 28.
Preliminary structures were calculated without any hydrogen
bond restraints, but these structures were consistent with hy-
drogen bonds across the 
-sheet between 24 HN and 31 CO, 26
HN and 29 CO, and 31 HN and 24 CO. The latter hydrogen
bond was not detected as a slow exchange amide, but this is
most likely due to the low intensity of the signal due to broad-
ening. Additional hydrogen bonds are present in several

-turns between the CO of residue i and HN of residue i3. In
particular, type I 
-turns are present between residues 4 and 7
and between 12 and 15, and there is a type IV 
-turn between
FIG. 3. Summary of the sequential
and medium NOE connectivities for
MrVIB. The chemical shift index (CSI
(23)) for each residue is shown as a bar
plot, with values of 1 indicating a shift
deviation from random coil values of
greater than 0.1 ppm. Short range NOEs
are shown beneath the sequence. The
thickness of the filled bars indicates rela-
tive NOE intensities. The 3JHN-H cou-
pling constants above 8 Hz are shown as
arrows pointing upward, and those below
6 Hz are represented as arrows pointing
downward. The positive  angle of Phe28
is represented as an open circle, and re-
straints of 100°  80° are shown with
open triangles. Residues with 1 angle re-
straints are shown with filled squares.
FIG. 4. Schematic diagram of the
secondary structure of MrVIB show-
ing the inter-strand NOEs (continu-
ous arrows) and potential hydrogen
bonds (broken lines). Inter-residual
HN-HN, H-HN, and H-H NOEs are
shown with arrows. The -carbon atoms
are labeled according to their residue
numbers. For clarity, sequential NOEs
are omitted. The hydrogen bonds were in-
ferred from slow exchange data and pre-
liminary structure calculations.
FIG. 5. The solution structure of
MrVIB in 50% CD3CN. The 20 lowest
energy solution structures of MrVIB are
superimposed over the backbone atoms
(N, C, and Cn) of residues 4–6 and 19–30
and shown in stereoscopic view. The well
defined regions are shown in red, and the
disordered loop corresponding to residues
7–18 is shown in blue.
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residues 20 and 23. The type I turn for residues 12–15 is
present in a region of the molecule having very few NOEs and
is consequently poorly defined. The structures also provide an
explanation for the observation of a signal from the N terminus
in TOCSY and NOESY spectra: 70% of the structures indicate
a hydrogen bond between the amino group of Ala1 and the
hydroxyl of Tyr18.
The disulfide bonds between Cys2 and Cys20 and between
Cys19 and Cys30 are classified as right-handed hooks in a
majority of the 20 final structures. The disulfide bond between
residues 9 and 25 does not have a single preferred geometry
throughout the structures. These structural findings are based
on the assumption that the disulfide connectivity reported pre-
viously (11) is correct, as seems likely, but to provide further
support for this suggestion additional calculations were done
with alternative connectivities. In previous studies, MrVIB was
synthesized with Cys9 and Cys25 selectively protected, and the
four remaining cysteine residues were allowed to form disulfide
bonds in a nonselective fashion (11). These four cysteine resi-
dues can theoretically form three connectivities, and structures
were calculated with each of these connectivities, keeping the
Cys9-Cys25 bond fixed. From these studies the Cys2-Cys20,
Cys9-Cys25, and Cys19-Cys30 disulfide set was found to have
significantly better fits to the experimental restraints. For
instance, the Cys2-Cys19, Cys9-Cys25, and Cys20-Cys30 connec-
tivity had several large NOE violations, including an average
violation of 0.71 Å for the NOE between Cys19 HB3 and Leu23
HN. The 1 angle restraint on Cys
19 also showed significant
violations for this connectivity (average violation of 15°). In the
Cys2-Cys30, Cys9-Cys25, and Cys19-Cys20 connectivity, a large
number of relatively small NOE violations were observed, and
again, the Cys19 1 angle restraint violated significantly (aver-
age violation of 31°) in addition to the 1 angle restraints of
Cys2 and Cys30 (average violations of 6.3° and 17.1°, respec-
tively). The connectivity pattern of CysI-CysIV, CysII-CysV, and
CysIII-CysVI confirmed in the current study to be present in
MrVIB is the same as is seen in a range of cystine knot struc-
tures (26). Analysis of the three-dimensional structure of
MrVIB suggests that the topology is that of an inhibitor cystine
knot (ICK) peptide (27).
Effects of MrVIA and MrVIB on Neuronal Whole Cell Na
Currents—The effects of O-conotoxins MrVIA and MrVIB on
peak TTX-R and TTX-S Na currents in rat DRG neurons were
investigated. Large diameter DRG neurons (capacitance 20–35
picofarads) exhibited mostly TTX-S Na currents with fast
activation and inactivation kinetics, whereas small (2–10 pico-
farads) and medium sized (10–20 picofarads) neurons exhib-
ited both fast TTX-S and slow TTX-R Na currents, similar to
that described previously (28, 29). Bath application of MrVIA
and MrVIB (1 M) reversibly reduced the peak amplitude of
both TTX-S (90% of current sensitive to 300 nM TTX) and
TTX-R Na currents in rat DRG neurons (Fig. 7). Concentra-
tion-response curves indicated that MrVIA and MrVIB exhibit
a similar potency, however, given that MrVIA was more readily
available than MrVIB, MrVIA was used for further experi-
TABLE I
Structural statistics for the 20 lowest energy structures of O-MrVIB
The values in the table are the mean  S.D.
Experimental restraints
Sequential NOEs 74
Medium range NOEs 38
Long range NOEs 77
Hydrogen bonds 10
Dihedral angles 15
Mean RMSDs from experimental
restraints
NOE distances (Å) 0.054  0.003
Dihedral angles (°) 0.55  0.14
Mean RMSDs from idealized covalent
geometry
Bonds (Å) 0.0044  0.0002
Angles (°) 0.55  0.04
Impropers (°) 0.41  0.04
Mean energies (kcal mol1)
ENOE
a 27.8  2.8
Ecdih
a 0.29  0.15
Ebond 9.3  0.87
Eangle 40.2  5.2
Eimproper 6.8  1.3
Evdw 36.1  9.9
Atomic RMSDs (Å)b
Backbone atoms (residues 4–6, 19–31) 0.29  0.10
Heavy atoms (residues 4–6, 19–31) 0.68  0.18
Ramachandran statistics (%)a
(residues 4–6, 19–31)
Residues in most favored regions 78.2
Residues in additional allowed
regions
21.8
Residues in disallowed regions 0.0
a Procheck_NMR was used to calculate the Ramachandran statistics.
b Atomic r.m.s.d. values are the pairwise RMS difference for the
family of structures.
FIG. 6. Comparison of linewidths of selected peaks in a region
of a NOESY spectrum of MrVIB recorded on a 750-MHz spec-
trometer at 290 K. The cross-peaks resulting from Val11 and Ile13 are
highlighted with boxes to indicate the increased linewidth relative to
other resonances.
FIG. 7. Effects of O-conotoxins MrVIA and MrVIB on tran-
sient Na currents in rat DRG neurons. Superimposed traces are
shown of depolarization-activated Na currents obtained in the absence
(control) and presence of 1 M MrVIA (A) and MrVIB (B). Washout of
MrVIA and -B resulted in 95% recovery of peak Na current amplitude.
This DRG neuron exhibited largely TTX-S Na current with a small
component of slowly inactivating TTX-R Na current.
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ments. MrVIA was found to have a 10-fold higher affinity for
inhibition of TTX-R than TTX-S Na currents in rat DRG
neurons (Fig. 8, A and B). The half-maximal inhibitory concen-
tration (IC50) for reduction of peak TTX-R Na
 current was
82.8 nM (n  7) and 1.02 M (n  7) for the TTX-S Na current
(Fig. 8B). The kinetics of onset and recovery from block by
MrVIA are shown for TTX-R and TTX-S Na currents in Fig. 9.
From this experiment, the Kd for the TTX-R Na
 current was
82 and 647 nM for the TTX-S Na current. The off-rate was
relatively similar for TTX-R versus TTX-S Na current, and Kd
was determined largely by the 10-fold difference in on-rate.
In addition, MrVIA did not change the current-voltage relation-
ship for either TTX-R or TTX-S Na current (Fig. 10). In a
series of experiments to examine the effect of MrVIA on voltage-
dependent Ca2 channels, MrVIA at concentrations of up to 10
M had no effect on depolarization-activated Ba2 current am-
plitude in rat DRG neurons (n  6) as shown in Fig. 11.
DISCUSSION
In this study, we have determined for the first time the
three-dimensional structure adopted by O-conotoxins and es-
tablished that members of this class act at a mammalian
TTX-R sodium channel. The O-conotoxins MrVIA and MrVIB
were found to inhibit both TTX-S and TTX-R Na currents in
rat DRG neurons, with IC50 values of 1 M and 80 nM,
respectively. The IC50 value for TTX-R Na
 currents is very
similar to that reported previously for inhibition of Na cur-
rents in molluscan neurons (11, 13), whereas the IC50 value for
TTX-S Na currents is 10 times higher. The binding site for
MrVIA/B on the VSSC is currently unknown but is distinct
from site 1 where -conotoxins bind (12).
The transient TTX-R Na current in DRG neurons appears
to be mediated by the Nav1.8/PN3/SNS VSSC subtype (31, 32).
Nav1.8 is expressed almost exclusively in small and medium
sized DRG neurons, most of which are nociceptors (33, 34), and
is up-regulated in inflammatory pain states (35, 36). The role of
Nav1.8 in pain was confirmed by studies of Nav1.8 null mutant
mice, which exhibited a decreased response to noxious mechan-
ical stimuli and reduced inflammatory-induced hyperalgesia
(3). These observations suggest that selective inhibition of
Nav1.8 could produce analgesia without side-effects (37–40).
The O-conotoxins, MrVIA and MrVIB, are the first known
peptide inhibitors of the mammalian TTX-R Na current in
DRG neurons, and it is possible that engineering of these toxins
could produce the first selective inhibitors for TTX-R Na
channels.
Analysis of the structures of the O-conotoxins has re-
vealed some interesting features that may have functional
significance. Both MrVIA and MrVIB aggregate in aqueous
solution at millimolar concentrations, based on the very
broad signals observed in the NMR spectra. This finding is
consistent with the late elution time on HPLC of these pep-
tides and their high content of hydrophobic residues. Al-
though the peptides visually appear to be soluble in aqueous
solution, the broad NMR peaks suggest that they are highly
aggregated. Certainly, dimers or small oligomers would not
be expected to result in the degree of broadening observed.
The presence of organic solvent, in particular acetonitrile,
substantially improved the quality of the spectra, presum-
ably by stabilizing a monomeric conformation.
The main element of secondary structure in MrVIB is a small
region of 
-sheet between residues 24 and 25 and between 30
and 31. The 
-sheet is stabilized by hydrogen bonds between 24
HN and 31 CO, 26 HN and 29 CO, and 31 HN and 24 CO.
Additional hydrogen bonds are also present to stabilize several

-turns in MrVIB, as well as to stabilize the N terminus.
Unusually, a signal from the N-terminal amino group is pres-
ent in the TOCSY and NOESY spectra. The unusually slow
exchange of the N-terminal amine appears to be the result of a
hydrogen bond with the hydroxyl of Tyr18.
Both strands involved in the 
-sheet of MrVIB contain cys-
teine residues that form disulfide bonds and connect the
strands to other regions, forming a compact core in the mole-
cule. The disulfide connectivity was previously established us-
ing synthetic methods to be Cys2-Cys20, Cys9-Cys25, and Cys19-
Cys30 (11). The NMR data in the current study have confirmed
this connectivity but also show that the disulfide bonds are
topologically arranged to form an ICK motif (27). This motif
involves the disulfide bonds between Cys2 and Cys20 and be-
tween Cys9 and Cys25 and their connecting backbone segments
forming a ring through which the Cys19 to Cys30 disulfide bond
threads. The knotted structure is likely to play a significant
role in stabilizing the overall fold.
The ICK motif is now known to be present in a variety of
proteins, many of which are toxins (26, 27). In particular, both
the - and -conotoxins contain a cystine knot motif (41, 42),
and a comparison of the structures of members of these families
with MrVIB is shown in Fig. 9. The overall fold is maintained
in all three families despite the sequence variation, suggesting
a crucial role for the disulfide bonds in maintaining the struc-
ture. Other studies on cystine knot proteins have also high-
FIG. 8. Effects of MrVIA on TTX-sensitive and TTX-resistant
Na currents in rat DRG neurons. In A: i, superimposed traces of
Na currents recorded from a DRG neuron exhibiting only fast, TTX-S
Na current. Depolarization-activated Na currents were obtained in
the absence (control) and presence of 100 nM MrVIA and were com-
pletely blocked by 300 nM TTX. ii, superimposed Na currents recorded
from a different DRG neuron in the presence of 300 nM TTX (TTX-
resistant Na current) in the absence (control) and presence of 100 nM
MrVIA. B, neurons exhibiting Na current that was abolished by 300
nM TTX (90%) were used for comparison of toxin affinity on TTX-R
versus TTX-S Na current. The half-maximal inhibitory concentration
(IC50) for the TTX-R Na
 current was 82.8 nM (n  7) and 1.02 M (n 
7) for the TTX-S Na current.
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lighted the importance of the disulfide bonds. For example, the
structures of disulfide isomers of -conotoxin GVIA differ sig-
nificantly from the native structure and have no activity at the
N-type calcium channel (43). Variations in activity have also
been seen for disulfide bond isomers of -conotoxins (44, 45).
Despite the structural similarities observed for the O-, -,
and -conotoxins, they clearly act in distinct ways that must be
related to structural differences. An analysis of the surface
features of the peptides shown in Fig. 12 reveals such differ-
ences. For instance, most of the surface of MrVIB is hydropho-
bic. It has previously been noted that the -conotoxin TxVIA
contains an unusual surface-exposed hydrophobic patch (Fig.
12) (41), but it is apparent from the present study that the
extent of hydrophobicity is quite different from O-MrVIB.
This is reflected in the differing aggregation states of the pep-
tides. The three-dimensional structure of TxVIA was deter-
mined in aqueous solution at a quite high concentration (5
mM (41)), whereas MrVIA and MrVIB appear to aggregate in
aqueous solution at much lower concentrations (1 mM). Both
TxVIA and MVIIA have a larger number of hydrophilic and
charged residues than MrVIB, and this is highlighted in Fig.
12. The hydrophobic patch of TxVIA has been implicated in
playing an important role in binding to sodium channels.
MrVIB has a hydrophobic patch in a similar location but, as
FIG. 9. Time course of onset and re-
covery from block of depolarization-
activated TTX-sensitive and TTX-re-
sistant Na currents by MrVIA. A, the
relative peak Na current amplitude plot-
ted as a function of time during bath ap-
plication of 100 and 300 nM MrVIA and
upon washout. TTX-R Na current was
recorded in the presence of 300 nM TTX
(n  4). Representative TTX-R Na cur-
rents corresponding to those elicited be-
fore and during the onset and recovery
from block are shown below. B, the rela-
tive peak TTX-sensitive Na current am-
plitude plotted as a function of time dur-
ing bath application of 1 M MrVIA and
upon washout (n  3). Error bars ( S.E.)
are obscured by the data points. Repre-
sentative TTX-S Na currents recorded at
different times before and during the on-
set and recovery from block are shown
below. From estimates of on- and off-rates
the Kd for inhibition of the TTX-R Na

current was 82 nM and for the TTX-S Na
current was 647 nM.
FIG. 10. Current-voltage relation-
ships of TTX-R (A) and TTX-S (B) Na
currents obtained in the absence
(control) and presence of MrVIA.
TTX-R Na currents recorded in the pres-
ence of 300 nM TTX were inhibited by 100
nM MrVIA, whereas TTX-S Na currents
were inhibited by 1 M MrVIA.
FIG. 11. Depolarization-activated Ca2 channel currents in
DRG neurons are insensitive to MrVIA. Superimposed Ba2 cur-
rents in response to step depolarization from 120 mV to 20 mV
obtained in the absence (control) and presence of 1 M and 10 M
MrVIA. Depolarization-activated Ba2 currents were recorded in a
Na-free extracellular solution containing 4 mM Ba2.
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mentioned above, also has a large number of other surface-
exposed hydrophobic residues, and therefore it is difficult to
predict if this particular region plays a role in binding to the
receptor. Mutagenesis studies will be necessary to elucidate the
importance of various surface residues.
The most striking difference between MrVIB and the - and
-conotoxins is the disorder observed in loop 2 of MrVIB. Re-
laxation experiments will be required to determine if this dis-
order is a result of structural flexibility or if indeed the aggre-
gation observed in aqueous solution that appears to be
modulated by acetonitrile is responsible for the disorder. Such
a disordered loop is unprecedented in the O superfamily cono-
toxins, although a limited degree of flexibility has been re-
ported for loop 2 of the -conotoxin MVIIA. In that case, it is
known that loop 2 is critical for high affinity binding to voltage-
gated calcium channels. Broadening of peaks from residues
11–13 suggested slow conformational exchange (42), and this
was also supported by NMR relaxation measurements (46). It
has been suggested that this conformational exchange may
have functional significance and may allow MVIIA to bind to
two different receptor subtypes in the molluscs that it preys
upon (46).
Flexibility in proteins is increasingly being taken into ac-
count in drug design applications, because disordered regions
can allow variability in protein recognition motifs, permitting a
given sequence to adaptively recognize multiple binding part-
ners (47). The apparent flexibility observed in the structure of
MrVIB reported here may have implications for its cross-chan-
nel activity at the mollusc neuronal sodium and calcium chan-
nels in addition to activity at both TTX-R and TTX-S mamma-
lian sodium channels.
The unusual cross channel activity at both sodium and cal-
cium channels in molluscan neurons has been observed in at
least three other peptide toxins, namely the tarantula peptides
ProTx-I and ProTx-II (48) and the -scorpion-toxin-like pep-
tide, kurtoxin (49). The only sequence conservation between
these peptides and MrVIA/MrVIB is the high content of cys-
teine residues, with the ProTx peptides containing six cysteine
residues and kurtoxin containing eight. The disulfide connec-
tivity has been elucidated for the ProTx peptides and shown to
be CysI-CysIV, CysII-CysV, and CysIII-CysVI (48). It has been
suggested that they contain an inhibitor cystine knot motif
based on this connectivity. Because the three-dimensional
structures of these toxins have not been reported, it remains to
be seen if structural flexibility is also a distinguishing feature
of these toxins. Structural analysis may assist in determining
key features of these toxins that interact with both sodium and
calcium channels. Other peptide toxins containing a cystine
knot motif that have been implicated in sodium channel activ-
ity include GS (50) and TVIIA (30).
In summary, we have shown MrVIA and MrVIB to be the
first peptidic inhibitors of the transient TTX-R Na current in
rat DRG neurons. The equivalent ion channels in humans are
therapeutic targets for the treatment of pain. Furthermore, we
have used NMR spectroscopy to provide the first structural
information on this class of conotoxins. A disordered loop 2 in
the structure of MrVIB is likely to result from structural flex-
ibility and may allow binding to calcium and TTX-R and TTX-S
sodium channels. However, structure activity studies are re-
quired to provide information on the importance of particular
residues in binding to these different ion channels.
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